investment report

The January 2020 issue of Research!America's newsletter, The Research Advocate, is now online! In this issue: See the results of our latest survey conducted in partnership with members American Society for Human Genetics : Research!America-ASHG Survey Finds Americans Strongly Support Human Genetics Research . The survey finds the large majority of Americans agree genetic knowledge will be important to their own health and their families’ health. Americans also express great curiosity about genetics, as well as interest in what it tells us about human history and our common heritage as a species. Is the position of the U.S. in global science and engineering slipping ? Find out in the new...
Dear Research Advocate, Almost three months into the 2020 fiscal year, Congress has finally passed a legislative package to fund the federal government. As of press time, the Senate is expected to finish clearing the package tonight. The White House has indicated that the President will sign, thus avoiding a shutdown at midnight on Friday. There are many positive developments for the medical and science research advocacy community in these bills, including: A significant funding increase of $2.6 billion for NIH, paving the way for faster medical progress and more lifesaving, job-producing R&D. An increase of $636 million for the CDC, including new resources to strengthen the agency’s 24...
U.S. investments in medical and health research and development (R&D) grew by 13.3% over a three year period (2013 – 2015), according to Research!America’s new investment report . However, medical and health R&D represents a small fraction of total spending on health. Currently, the U.S. spends less than 5 cents of every health dollar on R&D to prevent, treat, and cure disease. More than half of Americans (56%) say that is not enough, a recent public opinion survey shows. Industry, including pharmaceutical, medical technolo­gy, biotechnology and health IT companies, invests more in R&D than other sectors. In 2015, industry invested 64.7% of total spending, followed by the...
Dear Research Advocate: Here’€™s a holiday surprise! I am not referring to the budget deal, but to the fact that Merriam-Webster’€™s 2013 word of the year ’€” determined via the greatest increase in online searches ’€” is “science.” I find this to be refreshing news, providing evidence that interest in science is growing, which in turn is an indication of substantial room for researchers and research advocates to contribute to public understanding and support of science. We appear to have an opportunity ready for the taking to overcome the “invisibility” problem that contributes to holding decision makers back from assigning a higher priority to science. And speaking of those decision...
Federal R&D Funding Remains ’€œWoefully Inadequate’€ to Address Health Threats and Global Competitiveness Highlights: Overall health R&D spending in the U.S. increased by $4.3 billion (3.5%). Industry, philanthropy and voluntary associations led gains in R&D spending. Federal R&D spending rose 2.2% but a considerable amount is the result of agency reorganization and reclassification. ALEXANDRIA, Va.’€” December 17, 2013 ’€” After declining in FY10-11, health-related research and development (R&D) spending in the U.S. increased by $4.3 billion (3.5%) in FY11-12, according to Truth and Consequences: Health R&D Spending in the U.S. (FY11-12), the 10th edition from...
Dear Research Advocate, Sandy was a terrifying October surprise. The devastation in New York and New Jersey is extensive, and it will take a long time to rebuild and to heal. It’€™s a reminder that not everything is about the election. That said, it is impossible not to think about a major election theme ’€” the role of government ’€” and also to think about climate change, one of many science topics not being discussed in this election season. Yet decisions involving the future of science will be made by those elected. That’€™s why we need to turn up the advocacy volume as loud as possible after the election, when the lame-duck Congress and the administration, closely watched and...
Pending Budget Cuts will Further Jeopardize Global Leadership in Research and Innovation WASHINGTON, DC ’€”October 25, 2012’€”Biomedical and health research and development (R&D) spending from all sources declined by more than $4 billion or 3% between FY10 and FY11 according to Research!America’€™s 2011 U.S. Investment in Health Research report. This represents the first drop in overall spending since Research!America began compiling the data in 2002. The decline follows an uptick in research funding attributed to the American Recovery and Reinvestment Act (ARRA), which allocated $10.4 billion to the National Institutes of Health (NIH) over two fiscal years (2009-2010). The overall...
Dear Research Advocate, Nine times. That’€™s how often the word ’€œresearch’€ was used in Monday’€™s third and final presidential debate. Clearly, both candidates recognize the importance of research and the role it plays in keeping our nation competitive. The election and decision-making around deficit reduction will put this rhetoric to the test. I was thankful for the opportunity to contribute to an article in Nature on the outlook for research and the candidates’€™ sometimes competing, sometimes intersecting visions for our nation. Many indicators point to the need for a ’€œgrand bargain’€ to avoid the fiscal cliff we have talked so much about. Rumors have it that informal talks are...

Sidebar Quote

Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor